These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2184877)

  • 1. An overview in the treatment of advanced ovarian cancer. MRC Gynaecological Cancer Working Party.
    Br J Cancer; 1990 Apr; 61(4):495-6. PubMed ID: 2184877
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?
    Vergote I; Amant F; Leunen K
    Gynecol Oncol; 2010 Oct; 119(1):1-2. PubMed ID: 20833283
    [No Abstract]   [Full Text] [Related]  

  • 3. Gynaecological cancer: ADAMTS mutations predict sensitivity to chemotherapy in ovarian cancer.
    Errico A
    Nat Rev Clin Oncol; 2015 Sep; 12(9):504. PubMed ID: 26122182
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgical practice of UK gynaecological oncologists in the treatment of primary advanced epithelial ovarian cancer (PAEOC): a questionnaire survey.
    Barton DP; Adib T; Butler J
    Gynecol Oncol; 2013 Nov; 131(2):347-51. PubMed ID: 23954901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for advanced ovarian cancer. Advanced Ovarian Cancer Trialists Group.
    Stewart L;
    Cochrane Database Syst Rev; 2000; (2):CD001418. PubMed ID: 10796788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomic considerations in treating ovarian cancer.
    Bodurka-Bevers D; Sun CC; Gershenson DM
    Pharmacoeconomics; 2000 Feb; 17(2):133-50. PubMed ID: 10947337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced epithelial ovarian cancer: from standard chemotherapy to promising molecular pathway targets--where are we now?
    Syrios J; Banerjee S; Kaye SB
    Anticancer Res; 2014 May; 34(5):2069-77. PubMed ID: 24778008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The results of a quantitative overview of chemotherapy in advanced ovarian cancer: what can we learn?
    Stewart LA; Parmar MK
    Bull Cancer; 1993 Feb; 80(2):146-51. PubMed ID: 8173166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.
    BMJ; 1991 Oct; 303(6807):884-93. PubMed ID: 1834291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Therapies for Ovarian Cancer.
    Grunewald T; Ledermann JA
    Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():139-152. PubMed ID: 28111228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers.
    Wiseman LR; Spencer CM
    Drugs Aging; 1998 Apr; 12(4):305-34. PubMed ID: 9571394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of an overview of chemotherapy in advanced ovarian carcinoma.
    Williams CJ
    Br J Cancer; 1992 Aug; 66(2):225-6. PubMed ID: 1503894
    [No Abstract]   [Full Text] [Related]  

  • 14. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer.
    Jaaback K; Johnson N
    Cochrane Database Syst Rev; 2006 Jan; (1):CD005340. PubMed ID: 16437527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for advanced ovarian cancer: overview of randomized trials.
    Thigpen JT
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):11-6. PubMed ID: 10952121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the management and the role of intraperitoneal chemotherapy for ovarian cancer.
    Teo MC
    Curr Opin Obstet Gynecol; 2014 Feb; 26(1):3-8. PubMed ID: 24247932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The place of surgery in the treatment of ovarian cancer.
    Hudson CN
    Clin Obstet Gynaecol; 1978 Dec; 5(3):695-708. PubMed ID: 737947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Update on current care guidelines: ovarian cancer].
    Leminen A; Auranen A; Bützow R; Hietanen S; Komulainen M; Kuoppala T; Mäenpää J; Puistola U; Vuento M; Vuorela P; Yliskoski M
    Duodecim; 2012; 128(12):1300-1. PubMed ID: 22822606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Made-to-measure medicine: BRCA and gynaecological cancer.
    Foulkes WD
    Lancet Oncol; 2014 Jul; 15(8):783-5. PubMed ID: 24882435
    [No Abstract]   [Full Text] [Related]  

  • 20. Second-line treatment of first relapse recurrent ovarian cancer.
    Chua TC; Liauw W; Robertson G; Morris DL
    Aust N Z J Obstet Gynaecol; 2010 Oct; 50(5):465-71. PubMed ID: 21039382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.